ImmunoPrecise Antibodies Ltd.

TSXV:IPA Stock Report

Market Cap: CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ImmunoPrecise Antibodies Management

Management criteria checks 2/4

Key information

Jennifer Bath

Chief executive officer

CA$1.9m

Total compensation

CEO salary percentage34.9%
CEO tenure4.8yrs
CEO ownership0.4%
Management average tenure1.3yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

CEO Compensation Analysis

How has Jennifer Bath's remuneration changed compared to ImmunoPrecise Antibodies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Compensation vs Market: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Compensation vs Earnings: Jennifer's compensation has been consistent with company performance over the past year.


CEO

Jennifer Bath

4.8yrs

Tenure

CA$1,856,482

Compensation

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...


Leadership Team

NamePositionTenureCompensationOwnership
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrsno datano data
Carla Dahl
Vice President of Marketing1.3yrsno data0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno datano data0.0048%
CA$ 7.8k

1.3yrs

Average Tenure

Experienced Management: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00kno data
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrsno datano data
Anna Pettersson
Independent Directorless than a yearCA$75.55kno data

4.5yrs

Average Tenure

57yo

Average Age

Experienced Board: IPA's board of directors are considered experienced (4.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.